In normal tissue and premalignant lesions, TGF-β ligands demonstrate antiproliferative effects, while as cancers progress, TGF-β signaling takes on a more tumor-promoting role including the induction of EMT or tumor cell migration and invasion [1]. This evidence concerns the gene TGFB1 and neoplasm.